Vitura Health Limited (ASX:VIT)
Australia · Delayed Price · Currency is AUD 0.0200
-0.0010 (-4.76%)
Sep 11, 2026, 10:22 AM AEST
Vitura Health Ratios and Metrics
Market cap in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
| 14 | 17 | 41 | 50 | 287 | 138 | |
Market Cap Growth | -68.16% | -59.65% | -17.09% | -82.72% | 108.21% | 918.26% |
Enterprise Value | 24 | 25 | 51 | 48 | 276 | 126 |
Last Close Price | 0.02 | 0.03 | 0.06 | 0.08 | 0.49 | 0.23 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | - | - | 12.35 | 14.10 | 20.76 | 22.76 |
Forward PE | - | 4.95 | 4.95 | 4.95 | 15.03 | - |
PS Ratio | 0.11 | 0.13 | 0.33 | 0.40 | 2.44 | 2.06 |
PB Ratio | 0.32 | 0.39 | 0.86 | 1.29 | 8.21 | 5.28 |
P/TBV Ratio | 2.94 | 3.50 | 5.16 | 6.56 | 10.28 | 7.27 |
P/FCF Ratio | - | - | 15.89 | 7.43 | 32.64 | 10.48 |
P/OCF Ratio | - | - | 15.39 | 7.08 | 29.52 | 10.19 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
EV/Sales Ratio | 0.19 | 0.19 | 0.41 | 0.39 | 2.36 | 1.88 |
EV/EBITDA Ratio | - | - | 7.60 | 8.36 | 13.66 | 12.44 |
EV/EBIT Ratio | - | - | 9.76 | 9.93 | 13.91 | 12.69 |
EV/FCF Ratio | - | - | 19.79 | 7.25 | 31.47 | 9.58 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Debt / Equity Ratio | 0.38 | 0.38 | 0.25 | 0.29 | 0.04 | 0.19 |
Debt / EBITDA Ratio | - | - | 1.59 | 1.69 | 0.06 | 0.48 |
Debt / FCF Ratio | - | - | 4.63 | 1.65 | 0.15 | 0.39 |
Net Debt / Equity Ratio | 0.26 | 0.26 | 0.09 | -0.01 | -0.50 | -0.42 |
Net Debt / EBITDA Ratio | -6.53 | -6.53 | 0.65 | -0.06 | -0.87 | -1.09 |
Net Debt / FCF Ratio | -50.95 | -50.95 | 1.70 | -0.05 | -2.00 | -0.84 |
Asset Turnover | 1.72 | 1.72 | 1.69 | 2.10 | 2.62 | 2.59 |
Inventory Turnover | 20.32 | 20.32 | 16.43 | 15.04 | 13.01 | 10.22 |
Quick Ratio | 0.62 | 0.62 | 0.96 | 1.07 | 2.59 | 1.79 |
Current Ratio | 0.79 | 0.79 | 1.37 | 1.33 | 3.31 | 2.27 |
Return on Equity (ROE) | -9.73% | -9.73% | 7.12% | 8.86% | 45.10% | 40.03% |
Return on Assets (ROA) | -1.65% | -1.65% | 4.46% | 5.15% | 27.66% | 24.00% |
Return on Invested Capital (ROIC) | -3.73% | -3.80% | 7.57% | 12.50% | 84.10% | 69.34% |
Return on Capital Employed (ROCE) | -4.50% | -4.50% | 9.30% | 10.20% | 55.10% | 32.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Earnings Yield | -31.56% | -26.51% | 8.10% | 7.09% | 4.82% | 4.39% |
FCF Yield | -1.56% | -1.31% | 6.29% | 13.46% | 3.06% | 9.54% |
Dividend Yield | - | - | 3.32% | - | 2.05% | 4.30% |
Payout Ratio | - | - | - | 154.83% | 39.56% | - |
Buyback Yield / Dilution | -8.65% | -8.65% | -7.01% | 0.33% | -17.44% | -21.21% |
Total Shareholder Return | -8.65% | -8.65% | -3.69% | 0.33% | -15.39% | -16.90% |